National Healthcare Properties, Inc.
NHPAP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | 0.84 | -24.58 | -0.47 |
| FCF Yield | -24.34% | -0.16% | 0.05% | 2.76% |
| EV / EBITDA | -69.15 | 20.98 | 30.47 | 41.16 |
| Quality | ||||
| ROIC | -6.70% | -0.23% | -1.49% | -1.74% |
| Gross Margin | 37.49% | 37.04% | 36.45% | 37.51% |
| Cash Conversion Ratio | 0.42 | -0.30 | -0.36 | -0.46 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.75% | 1.65% | -4.17% | -4.23% |
| Free Cash Flow Growth | -13,063.52% | -355.96% | -98.48% | -0.54% |
| Safety | ||||
| Net Debt / EBITDA | -50.45 | 14.72 | 19.55 | 24.29 |
| Interest Coverage | -1.78 | -0.07 | -0.61 | -0.78 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -124.28 | -53.26 | -49.90 | -49.30 |